GAP43 and neurodegenerative disease: Further exploration of these areas using human-derived neuronal lines will be crucial to corroborate the effects of GAP-43 S86 and T172 phosphomimetic mutants and facilitate the development of GAP-43-targeting therapies for neurodegenerative diseases.